MGC Pharmaceuticals (AU:MXC)

MGC Pharmaceuticals (MXC) Financial Statements


MGC Pharmaceuticals Financial Overview

MGC Pharmaceuticals's market cap is currently ―. The company's EPS TTM is AU$-7.07; its P/E ratio is -0.08; MGC Pharmaceuticals is scheduled to report earnings on February 26, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 1.89M$ 5.43M$ 1.87M$ 2.35M$ 9.86M
Total Assets$ 18.56M$ 24.24M$ 7.93M$ 13.00M$ 19.99M
Total Debt$ 4.35M$ 6.02M$ 1.90M$ 0.00$ 21.56K
Net Debt$ 2.47M$ 584.33K$ 25.85K$ -2.35M$ -9.84M
Total Liabilities$ 13.38M$ 10.41M$ 4.83M$ 2.20M$ 7.30M
Stockholders Equity$ 5.84M$ 13.83M$ 3.11M$ 10.96M$ 13.93M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

MGC Pharmaceuticals Earnings and Revenue History

MGC Pharmaceuticals Debt to Assets

MGC Pharmaceuticals Cash Flow

MGC Pharmaceuticals Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis